Loading...

NXGL NEXGEL INC Company Mergers 8-K Filing

NXGL

NXGL

NEXGEL INC

(NXGL)

2026 8-K

Securities Offering

Board Appointments

CFO Appointment

Stock Listing Alert

License Agreement Update

Asset Acquisition Agreement

Convertible Notes Issued

Board Resignation

Management Change

Company Spin-off

Board Meeting Cancelled

Quarterly Results

Equity Offerings

Strategic Alliances

Rights Offerings

Investor Meetings

Financial Statements

Investor Presentation

Financial Results

Q4 Revenue Update

Management Changes

Quarterly Results

Investor Presentation

Preliminary Revenue

Financial Results

Regulation FD Disclosure

Earnings Reports

Annual Meeting of Stockholders

Acquisition of Silly George...

Earnings Reports

Earnings Reports

Subscription Agreements for...

Regulation FD Disclosure

Resignation of Director

Employment Agreement

Resignation of Director

Partnership Announcement

Asset Purchase Agreement

Financial Results

Supply Agreement with AbbVi...

Financial Results and Inves...

Annual Meeting of Stockholders

Investor Presentation

Results of Operations and F...

Earnings Reports

Services Agreement with Gla...

Acquisition of Joint Venture

Board Appointment and Resig...

Entry Into a Material Defin...

External Links:

On March 6, 2026, NEXGEL, INC. entered into an Asset Purchase and Exclusive License Agreement with Celularity, Inc. for up to $35 million, including a $15 million upfront payment and potential milestone payments of $20 million based on sales.

AI Assistant

NEXGEL INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.